Follow us on X
Follow us on LinkedIn
Follow us on Youtube
Discover RISE d.o.o

PneumoNP

Nanotherapeutics to Treat Antibiotic Gram-Negative Pneumonia Infections


Description

Infections due to antibiotic resistant Gram-negative bacteria are one of the major issues currently affecting global health, largely due to a lack of effective antibiotic therapy for this type of infection. The PneumoNP team will therefore specifically focus its attention on the pathogen Klebsiella pneumoniae, a global cause of antibiotic resistant infections. PneumoNP will generate: a new inhalable drug system composed of a nanotherapeutic system combining an antimicrobial peptide or active pharmaceutical ingredient (API) and a nanocarrier; a new aerosol technology specifically developed for the nanotherapeutic system; an innovative efficiency-efficacy test to follow-up the treatment; a new diagnostic kit for the rapid and multiplex identification of bacteria causing respiratory infections.

Coordinator
Dr. Iraida Loinaz
IK4 CIDETEC
Email
Programme
FP7
Duration
48 months (January 2014 - December 2017)
Project funding
€ 5,682,351.00
Project partners
11
Technology readiness level
2-4
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Germany
Phone: +49 6894 388130
Email
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Germany
Phone: +49 30 374415840
Email